简体中文 | 繁體中文 | English

Products & Services News

2018-12-06 10:18 EverZinc Invests in Zano®
2018-12-06 10:13 Seattle Genetics and Takeda Present Positive Data from Phase 3 ECHELON-2 Clinical Trial for ADCETRIS® (Brentuximab Vedotin) in Frontline Treatment of CD30-Expressing Peripheral T-Cell Lymphomas
2018-12-06 10:00 Diligent Launches First Global Governance Think-Tank with Diligent Institute
2018-12-06 09:53 Moody’s Analytics Launches Accelerator to Fast Track Innovation and Explore New Markets
2018-12-06 09:47 A.M. Best Affirms Credit Ratings of China Reinsurance (Group) Corporation and Its Subsidiaries
2018-12-05 18:41 GSMA’s Mats Granryd Appointed to UN Task Force on Digital Financing of the Sustainable Development Goals
2018-12-05 13:50 Tricor Bolsters Labuan Offering with Acquisition of CP TRUST Co. Ltd.
2018-12-05 10:28 Broadcom Inc. and HCL Technologies Announce a Global Preferred Services Partnership
2018-12-05 10:25 Video Collaboration Product eyeson Hits 1.5 Million Users and 1 Million App Downloads
2018-12-05 09:56 ABB enables groundbreaking trial of remotely operated passenger ferry
2018-12-05 09:54 Mopria Alliance Launches Mopria Scan App and Universal Standard
2018-12-05 09:51 MulteFire Alliance Completes Its IoT Optimized Specification
2018-12-04 16:46 Takeda to Present Positive Data from TOURMALINE-MM3, First Pivotal Phase 3 Placebo Controlled Trial Evaluating Proteasome Inhibitor Treatment in Maintenance Setting
2018-12-04 16:45 Värde Partners Closes First Dedicated Asia Credit Fund
2018-12-04 16:08 Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
2018-12-04 10:30 C3Nano Announces the Opening of its First Mass Production Factory in China
2018-12-04 10:23 A CMI Solar Receiver Will Equip the World's Tallest Solar Tower in Dubai
2018-12-04 09:56 Argon Design Licenses Argon Streams AV1 to Realtek Semiconductor
2018-12-04 09:54 Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018
2018-12-04 09:52 Kyriba Continues to Expand its #1 Global Solutions Ecosystem with New WorldFirst Partnership

Business Wire Weibo

Press Releases

Latest Releases